Masami Bessho

Author PubWeight™ 28.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial 2010 1.71
2 Is macrocytosis a favourable prognostic factor in myelodysplastic syndrome patients without increased blasts? Br J Haematol 2003 1.39
3 Primary pulmonary plasmacytoma involving bilateral lungs and marked hypergammaglobulinemia: differentiation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Leuk Res 2005 1.27
4 Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 2005 1.16
5 The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma. Cancer Genet Cytogenet 2008 1.11
6 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients. Ther Apher Dial 2004 0.95
7 Successful radiotherapy in a patient with primary rectal mucosa-associated lymphoid tissue lymphoma without the API2-MALT1 fusion gene: a case report and review of the literature. Leuk Res 2007 0.94
8 Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 2007 0.92
9 Cardiac resurrection after bone-marrow-derived mononuclear cell transplantation during left ventricular assist device support. Ann Thorac Surg 2007 0.91
10 Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML. Blood 2004 0.91
11 Primary cutaneous anaplastic large-cell lymphoma presenting with hemophagocytic syndrome: a case report and review of the literature. Leuk Res 2009 0.90
12 Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes. Leuk Res 2010 0.89
13 Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study. Int J Hematol 2004 0.84
14 Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma. Cancer Sci 2007 0.83
15 A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11)(p25;q35;p15) in an adult patient with myelodysplastic syndrome/acute myelogenous leukemia. Int J Hematol 2007 0.82
16 Impacts of recombinant human erythropoietin treatment during predialysis periods on the progression of chronic kidney disease in a large-scale cohort study (Co-JET study). Ther Apher Dial 2013 0.82
17 A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report. Mol Cytogenet 2012 0.80
18 Renal intravascular large B-cell lymphoma with early diagnosis by renal biopsy: a case report and review of the literature. Leuk Res 2008 0.80
19 Multiple myeloma with monosomy 13 developed in trisomy 13 acute myelocytic leukemia: numerical chromosome abnormality during chromosomal segregation process. Cancer Genet Cytogenet 2003 0.79
20 Clinical features of adult acute leukemia with 11q23 abnormalities in Japan: a co-operative multicenter study. Int J Hematol 2008 0.79
21 Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia. Int J Hematol 2005 0.79
22 Serum levels of Thl/Th2 cytokines, angiogenic growth factors, and other prognostic factors in young adult patients with hemophagocytic syndrome. Lab Hematol 2006 0.79
23 Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients. Ther Apher Dial 2014 0.78
24 Diagnostic significance of serum soluble transferrin receptors in various anemic diseases: the first multi-institutional joint study in Japan. Haematologia (Budap) 2002 0.78
25 Long-term follow-up of patients with aplastic anemia and refractory anemia responding to combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin. Int J Hematol 2002 0.77
26 Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study. Int J Hematol 2009 0.76
27 Clonal T cells of pure red-cell aplasia. Am J Hematol 2005 0.76
28 Phase II study of the CPT-11, mitoxantrone and dexamethasone regimen in combination with rituximab in elderly patients with relapsed diffuse large B-cell lymphoma. Cancer Sci 2006 0.76
29 In vitro thymidine kinase/ganciclovir-based suicide gene therapy using replication defective herpes simplex virus-1 against leukemic B-cell malignancies (MCL, HCL, B-CLL). Leuk Res 2003 0.75
30 Long-term improvement of anaemia in a patient with aplastic anaemia by short-term administration of pegylated recombinant human megakaryocyte growth and development factor. Br J Haematol 2004 0.75
31 A molecular analysis of biclonal follicular lymphoma: further evidence for bone marrow origin and clonal selection. Eur J Haematol 2009 0.75
32 A Case of Monoclonal Lymphoplasmacytosis of the Bone Marrow with IgM-Positive Russell Bodies. Bone Marrow Res 2011 0.75
33 [Systemic capillary leak syndrome presenting remarkable erythrocytosis]. Rinsho Ketsueki 2002 0.75
34 Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas. Leuk Res 2002 0.75
35 Assessment of the international prognostic scoring system for determining chemotherapeutic indications in myelodysplastic syndrome: Japanese retrospective multicenter study. Int J Hematol 2005 0.75
36 [De novo CD5-positive diffuse large B-cell lymphoma with leukemic dissemination diagnosed by immunohistochemical examinations of bone marrow clot sections]. Rinsho Ketsueki 2002 0.75
37 [Disappearance of CD 20 after treatment with rituximab of mantle cell lymphoma]. Rinsho Ketsueki 2003 0.75
38 Soluble transferrin receptor and its ratio to erythroblasts in bone marrow may be a new diagnostic tool to distinguish between aplastic and refractory anemia. Acta Haematol 2004 0.75
39 [Retrospective analysis of progression to multiple myeloma or related disorders in 114 patients with monoclonal gammopathy of undetermined significance in a single institute]. Rinsho Ketsueki 2012 0.75
40 Ratio of transferrin (Tf) to Tf-receptor complex in circulation differs depending on Tf iron saturation. Clin Chem 2002 0.75
41 Correlation between dysplastic lineage and type of cytopenia in myelodysplastic syndromes patients with refractory anemia according to the FAB classification. Am J Clin Pathol 2013 0.75
42 t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma. Leuk Res 2006 0.75
43 [Diffuse large B-cell lymphoma with strongly positive MIB-1 stain and clinical features resembling Burkitt lymphoma]. Rinsho Ketsueki 2005 0.75
44 [Successful treatment with CHOP therapy for progressive of primary macroglobulinemia without further increase of serum IgM]. Rinsho Ketsueki 2005 0.75
45 [Clinical application of hematopoietic factors]. Nihon Naika Gakkai Zasshi 2002 0.75
46 [Marfan syndrome complicated with CD5+ CD10+ diffuse large B-cell lymphoma]. Rinsho Ketsueki 2010 0.75
47 Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells. J Interferon Cytokine Res 2002 0.75
48 [Case with hairy cell leukemia-Japanese variant following radiotherapy for orbital adnexal MALT lymphoma]. Rinsho Ketsueki 2010 0.75
49 [POEMS syndrome presenting with transient immunoglobulin isotype switching after successful treatment with autologous peripheral blood stem cell transplantation]. Rinsho Ketsueki 2007 0.75
50 Lactate dehydrogenase-linked immunoglobulin Akappa in a patient with nonimmune chronic idiopathic neutropenia. Lab Hematol 2006 0.75
51 Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma. Hematol Oncol 2010 0.75
52 [Aplastic anemia complicated with ulcerative colitis]. Rinsho Ketsueki 2012 0.75
53 Plasma cell granuloma of the sigmoid colon associated with diverticular disease and accompanying IgM-type monoclonal gammopathy. Intern Med 2010 0.75
54 Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: does body weight matter? Am J Hematol 2008 0.75